Company
anavotx
UNLOCKING THE PHOSPHATASE TARGET CLASS
Also known as Anavo, Anavo Therapeutics, Anavo Therapeutics B.V.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Leiden, The Netherlands
- Customers
- partners
- Legal name
- Anavo Therapeutics B.V.
- anavotx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 17 September 2026
About
Anavo Therapeutics is at the forefront of phosphatase-based drug discovery with its IGNITE platform, a unique approach for accessing a space previously considered undruggable.
Funding snapshot
- Total raised
- $24MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Seed extension2023-05-02
Funding rounds
- Seed extension
- 2023-05-02
- Seed
- $24M2021-04-22, Company stated
Products
- Web
- IGNITE platform
Loading relationship preview